270 related articles for article (PubMed ID: 24518606)
1. Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
van der Have M; Mangen MJ; van der Valk ME; Smeets HM; van Bodegraven A; Dijkstra G; Fidder HH; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
Inflamm Bowel Dis; 2014 Apr; 20(4):637-45. PubMed ID: 24518606
[TBL] [Abstract][Full Text] [Related]
2. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
[TBL] [Abstract][Full Text] [Related]
3. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
[TBL] [Abstract][Full Text] [Related]
4. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Lee J; Im JP; Han K; Kim J; Lee HJ; Chun J; Kim JS
Gut Liver; 2020 Jan; 14(1):89-99. PubMed ID: 31158951
[No Abstract] [Full Text] [Related]
5. Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
Severs M; Petersen RE; Siersema PD; Mangen MJ; Oldenburg B
Inflamm Bowel Dis; 2016 Mar; 22(3):688-93. PubMed ID: 26835981
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
[TBL] [Abstract][Full Text] [Related]
7. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
[TBL] [Abstract][Full Text] [Related]
8. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
9. Cost of Illness in Inflammatory Bowel Disease.
Kamat N; Ganesh Pai C; Surulivel Rajan M; Kamath A
Dig Dis Sci; 2017 Sep; 62(9):2318-2326. PubMed ID: 28766243
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease: a Canadian burden of illness review.
Rocchi A; Benchimol EI; Bernstein CN; Bitton A; Feagan B; Panaccione R; Glasgow KW; Fernandes A; Ghosh S
Can J Gastroenterol; 2012 Nov; 26(11):811-7. PubMed ID: 23166905
[TBL] [Abstract][Full Text] [Related]
11. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease.
Colombara F; Martinato M; Girardin G; Gregori D
Inflamm Bowel Dis; 2015 Mar; 21(3):615-22. PubMed ID: 25636120
[TBL] [Abstract][Full Text] [Related]
12. Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.
Zand A; van Deen WK; Inserra EK; Hall L; Kane E; Centeno A; Choi JM; Ha CY; Esrailian E; DʼHaens GR; Hommes DW
Inflamm Bowel Dis; 2015 Jul; 21(7):1623-30. PubMed ID: 26070004
[TBL] [Abstract][Full Text] [Related]
13. Costs of inflammatory bowel disease in Germany.
Stark R; König HH; Leidl R
Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
[TBL] [Abstract][Full Text] [Related]
14. Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.
Franken MG; Leeneman B; Jochems A; Schouwenburg MG; Aarts MJB; van Akkooi ACJ; van den Berkmortel FWPJ; van den Eertwegh AJM; de Groot JWB; van der Hoeven KJM; Hospers GAP; Kapiteijn E; Koornstra R; Kruit WHJ; Louwman MWJ; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; Vreugdenhil G; Wouters MWJM; van Zeijl M; Haanen JBAG; Uyl-de Groot CA
Anticancer Drugs; 2018 Jul; 29(6):579-588. PubMed ID: 29634490
[TBL] [Abstract][Full Text] [Related]
15. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
16. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.
Feenstra TL; van Genugten ML; Hoogenveen RT; Wouters EF; Rutten-van Mölken MP
Am J Respir Crit Care Med; 2001 Aug; 164(4):590-6. PubMed ID: 11520721
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of patients with anemia in selected diseases.
Ershler WB; Chen K; Reyes EB; Dubois R
Value Health; 2005; 8(6):629-38. PubMed ID: 16283863
[TBL] [Abstract][Full Text] [Related]
18. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends.
Benchimol EI; Manuel DG; Guttmann A; Nguyen GC; Mojaverian N; Quach P; Mack DR
Inflamm Bowel Dis; 2014 Oct; 20(10):1761-9. PubMed ID: 25159453
[TBL] [Abstract][Full Text] [Related]
19. Health Care utilization in elderly onset inflammatory bowel disease: a population-based study.
Nguyen GC; Sheng L; Benchimol EI
Inflamm Bowel Dis; 2015 Apr; 21(4):777-82. PubMed ID: 25738376
[TBL] [Abstract][Full Text] [Related]
20. The global burden of IBD: from 2015 to 2025.
Kaplan GG
Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):720-7. PubMed ID: 26323879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
